Thus, manipulation of sphingolipid levels with drugs or nutrients can be useful approaches for the treatment of obesity by clinicians, particularly by aiming to decrease ceramide levels to have a positive effect on insulin/leptin resistance. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.